Suchergebnisse - (Subject:"Siltuximab")

PubPharm (121)

11

COVID-19 acute respiratory distress syndrome : A simulation study of the effects of combination therapy with tocilizumab and siltuximab

enthalten in: British journal of clinical pharmacology | 2022

von Doyle, E. | Bentley, D. | Dodds, M.

12

A New Approach to the Management of COVID-19. Antagonists of IL-6 : Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

13

Advances in clinical outcomes : What we have learned during the COVID-19 pandemic

enthalten in: The Journal of allergy and clinical immunology | 2022

von Al-Musa, A. | LaBere, B. | Habiballah, S. | +2

14

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Declercq, J. | Van Damme, K. | De Leeuw, E. | +40

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1353-1354. - PMID 34756179

15

Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation

enthalten in: Leukemia & lymphoma | 2021

von Ostrowska, B. | Szymczyk, A. | Olszewska-Szopa, M. | +8

16

Efficacy of IL-6 antagonists in the treatment of COVID-19 patients : further randomized controlled trials are warranted

enthalten in: Human cell | 2021

von Panda, A. | Padhi, S. | Pati, A. | +1

17

The management of Castleman disease

enthalten in: British journal of haematology | 2021

von Lomas, O. | Streetly, M. | Pratt, G. | +5

18

Idiopathic multicentric Castleman disease with TAFRO clinical subtype responsive to IL-6/JAK inhibition : A pediatric case series

enthalten in: Pediatric blood & cancer | 2021

von Lust, H. | Gong, S. | Remiker, A. | +1

19

Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19

enthalten in: Leukemia | 2021

von Gritti, G. | Raimondi, F. | Bottazzi, B. | +19

ErratumIn: Leukemia. 2021 Jun 28;:. - PMID 34183767

20

Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19

enthalten in: Thorax | 2021

von Khan, F. | Stewart, I. | Fabbri, L. | +4